Option chain shows key data for Opthea's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Opthea.

Opthea (OTC:CKDXF) Stock, Option Chain

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Opthea Ltd

Opthea Limited (AU:OPT) has released an update. Opthea Limited, listed on NASDAQ and the ASX, is focused on advancing its promising product candida...

Opthea Limited Advances Vision Treatment Amid Market Challenges

Opthea Limited (AU:OPT) has released an update. Opthea Limited, a biopharmaceutical company focused on retinal diseases, is set to engage with inve...

Opthea Set to Highlight Innovations at Investor Conferences

Opthea Limited (AU:OPT) has released an update. Opthea Limited, a biopharmaceutical company specializing in retinal disease treatments, announced i...

Opthea Limited to Present at Key November Investor Conferences

Opthea Limited (AU:OPT) has released an update. Opthea Limited, a biopharmaceutical company, is set to showcase its promising wet AMD treatment, so...

Opthea to Highlight Promising AMD Therapy at Key Events

Opthea Limited (AU:OPT) has released an update. Opthea Limited has achieved significant milestones in its quest to enhance treatment for wet age-re...

Opthea Limited Advances in Wet AMD Treatment

Opthea Limited (AU:OPT) has released an update. Opthea Limited has appointed Kathy Connell as a Non-Executive Director to its Board, bringing her e...

Opthea Limited Strengthens Board Amidst Key Data Preparations

Opthea Limited (AU:OPT) has released an update. Opthea Limited's 2024 Annual General Meeting concluded with all resolutions successfully carried, i...

Opthea Limited Announces Successful AGM Resolutions

Opthea Limited (AU:OPT) has released an update. Opthea Limited has bolstered its financial position with a A$15.9 million R&D tax incentive from th...

Opthea Secures A$15.9 Million Boost for R&D Efforts

Opthea Limited (AU:OPT) has released an update. Opthea Limited has announced the appointment of Ms. Katherine Connell as a new director, effective ...

Opthea Limited Appoints New Director with Stock Options

Opthea (OPT) announced the appointment of Kathy Connell to the Board of Directors as a Non-Executive Director. Ms. Connell's appointment was effect...

Comments

Opthea

Opthea (CKDXF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga